Organization · Venture Capital
Cypress Ridge Capital
Cypress Ridge Capital is a New York-based growth equity firm focused exclusively on healthcare investments. The firm targets innovative middle-market companies in various healthcare subsectors, aiming to support transformational growth.
Overview
What Cypress Ridge Capital does
What Cypress Ridge Capital is
Cypress Ridge Capital is a New York-based growth equity firm focused exclusively on healthcare investments. The firm targets innovative middle-market companies in various healthcare subsectors, aiming to support transformational growth.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Cypress Ridge Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cypress Ridge Capital as a funder
Investment thesis
Cypress Ridge Capital focuses exclusively on healthcare, targeting innovative middle-market companies pursuing transformational growth. The firm employs a thematic approach to invest in under-appreciated businesses and emerging market inflection points.
Focus narrative
Cypress Ridge Capital targets investments in a limited number of healthcare subsectors, including provider services, outsourced services, primary care, behavioral health, healthcare IT, and pharmaceutical services. The firm seeks to build market-leading companies through a combination of acquired and organic growth, focusing on businesses with revenues between $20 million and $100 million.
Value beyond capital
Cypress Ridge Capital adds value to its portfolio companies through a combination of capital investment, operational expertise, and strategic guidance. The firm focuses on transformational partnerships, leveraging its network of operating executives and functional experts to support growth and value creation post-investment.
Terms and economics
- Typical check
- $5,000,000–$75,000,000
- Sweet spot
- $20,000,000
Focus and fit
- Stages
- Growth Equity · Recap
- Sectors
- Healthcare
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
Portfolio context
Semaphore Solutions / Labbit: A laboratory informatics and SaaS platform for clinical, molecular diagnostics, biopharma, and manufacturing QC labs. Cresso Health: A technology-enabled sales and marketing platform for individual health-plan distribution, which acquired GPS Insurance in 2025. Atria Health: A physician-owned cardiovascular-care support platform that helps independent cardiology practices scale. GPS Insurance: A health-insurance distributor acquired by Cresso Health. Labbit: Semaphore's AI-powered lab workflow and configuration platform, with multiple product announcements in 2025.
Common questions
What to know about Cypress Ridge Capital
Upseed classifies Cypress Ridge Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.